Poplar Therapeutics
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $95M
Investors
- 6
About Poplar Therapeutics
, based in Boston, US, specializes in developing innovative anti-IgE therapies aimed at addressing allergic responses.Founded in 2024 in Boston, US, Poplar Therapeutics, Inc. is engaged in developing therapies for allergic diseases.Poplar Therapeutics specializes in the development of next-generation anti-IgE medicines that address critical health issues related to allergic conditions. Their innovative therapies enable patients to manage allergies more effectively, aiming to enhance the quality of life for individuals suffering from asthma and other IgE-mediated diseases.Poplar Therapeutics generates revenue through direct-to-consumer sales and partnerships with healthcare providers. The revenue model includes transactions for the sale of their anti-IgE therapies through established channels, incorporating both one-time purchases and ongoing supply agreements with clinics and hospitals to maintain a steady revenue stream.In March 2026, Poplar Therapeutics, Inc. The funds will support the continued clinical development of their lead program PHB-050, targeting food allergies and other atopic conditions. The company plans to expand into new markets, focusing on increasing market presence in Europe and Asia by 2027. Additionally, new product launches are anticipated as they progress in their clinical trials.
Who invested in Poplar Therapeutics
6 investors across 2 rounds
See all investors in Poplar Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Poplar Therapeutics
Who invested in Poplar Therapeutics?
Poplar Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Poplar Therapeutics raised?
Poplar Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Poplar Therapeutics last raise money?
Poplar Therapeutics's most recent round on record is a Series A, in Mar 2026.
What does Poplar Therapeutics do?
, based in Boston, US, specializes in developing innovative anti-IgE therapies aimed at addressing allergic responses.
Where is Poplar Therapeutics headquartered?
Poplar Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Poplar Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Poplar Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Poplar Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.